# SNC Therapeutics, Inc.

Canonical: https://abierto.us/vendors/snc-therapeutics-inc-ynqpl17kgwa6

- UEI: YNQPL17KGWA6
- CAGE: 253M3
- Location: Evanston, IL
- Awards in window: 2 (3 transactions), $6,997,810 obligated, September 24, 2026 to September 30, 2026

## Awarding agencies

- Departmental Offices: 2 awards, $6,997,810

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $3,499,423
- 541713 Research and Development in Nanotechnology: $3,498,387

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- 140D0426C0123 (definitive contract): $3,499,423, Ibc Acq SVCS Directorate. Arpa-H SNC Quiet STTR Phase II. https://www.usaspending.gov/award/CONT_AWD_140D0426C0123_1406_-NONE-_-NONE-/
- 140D0426C0122 (definitive contract): $3,498,387, Ibc Acq SVCS Directorate. Arpa-H SNC Shield STTR Phase II. https://www.usaspending.gov/award/CONT_AWD_140D0426C0122_1406_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/snc-therapeutics-inc-ynqpl17kgwa6.